Misconception: Human papillomavirus vaccine and infertility

Clinical Pediatrics

Volumn 53, Issue 2, 2014, Pages 158-165

  Schuler, Christine L ^a   Hanley, Chassidy J ^a   Coyne Beasley, Tamera ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

HPV; HPV vaccine; infertility; parent; side effects

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG INDUCED DISEASE; EDUCATIONAL STATUS; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MEDICAL INFORMATION; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PATIENT WORRY; SON; VACCINATION; VACCINE ASSOCIATED INFERTILITY;

HPV; HPV VACCINE; INFERTILITY; PARENT; SIDE EFFECTS;

ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFERTILITY, MALE; INTENTION; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION; YOUNG ADULT;

EID: 84892421904     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922813504026     Document Type: Article

References (38)

1. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006 ; 194: 1044-1057
2. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007 ; 297: 813-819
3. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006 ; 24: S3/35 - S3/41
4. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006 ; 24: S3/11 - S3/25
5. Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013 ; 105: 175-201
6. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010 ; 59: 626-629
7. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010 ; 59: 630-632
8. Recommen-dations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011 ; 60: 1705-1708
9. National and state vaccination coverage among adolescents aged 13-17 years - United States, 2011. MMWR Morb Mortal Wkly Rep. 2012 ; 61: 671-677
10. Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent males. Vaccine. 2011 ; 29: 5595-5602
11. Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010 ; 46: 113-123
12. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007 ; 45: 107-114
13. Marlow LA, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007 ; 25: 1945-1952
14. Highlights of prescribing information: Gardasil, no date, http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ UCM111263.pdf. Accessed February 7, 2013.
15. Slade BA, Leidel L, Vellozzi C, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009 ; 302: 750-757
16. Schuler CL, Reiter PL, Smith JS, Brewer NT. Human papillomavirus vaccine and behavioural disinhibition. Sex Transm Infect. 2011 ; 87: 349-353
17. Forster A, Wardle J, Stephenson J, Waller J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun. 2010 ; 15: 205-217
18. Watson M, Shaw D, Molchanoff L, McInnes C. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Aust N Z J Public Health. 2009 ; 33: 365-370
19. Bastani R, Glenn BA, Tsui J, et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomarkers Prev. 2011 ; 20: 1463-1472
20. Bingham A, Drake JK, LaMontagne DS. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med. 2009 ; 163: 455-461
21. Hopfer S, Clippard JR. College women's HPV vaccine decision narratives. Qual Health Res. 2011 ; 21: 262-277
22. Wise LD, Pauley CJ, Michael B, Wolf JJ. Lack of effects on male fertility from a quadrivalent HPV vaccine in Sprague-Dawley rats. Birth Defects Res B Dev Reprod Toxicol. 2010 ; 89: 376-381
23. Wise LD, Wolf JJ, Kaplanski CV, Pauley CJ, Ledwith BJ. Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats. Birth Defects Res B Dev Reprod Toxicol. 2008 ; 83: 561-572
24. Hopfer S, Clippard JR. College women's HPV vaccine decision narratives. Qual Health Res. 2011 ; 21: 262-277
25. Craciun C, Baban A. "Who will take the blame?": Understanding the reasons why Romanian mothers decline HPV for their daughters. Vaccine. 2012 ; 30: 6789-6793
26. Young A. HPV vaccine acceptance among women in the Asian Pacific: a systematic review of the literature. Asian Pac J Cancer Prev. 2010 ; 11: 641-649
27. Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984 ; 11: 1-47
28. Gilkey MB, Moss JL, McRee AL, Brewer NT. Do correlates of HPV vaccine initiation differ between adolescent boys and girls?. Vaccine. 2012 ; 30: 5928-5934
29. Sturm LA, Mays RM, Zimet GD. Parental beliefs and decision making about child and adolescent immunization: from polio to sexually transmitted infections. J Dev Behav Pediatr. 2005 ; 26: 441-452
30. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009 ; 18: 363-372
31. Cates JR, Shafer A, Carpentier FD, et al. How parents hear about human papillomavirus vaccine: Implications for uptake. J Adolesc Health. 2010 ; 47: 305-308
32. Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunizations? A national telephone survey. Pediatrics. 2000 ; 106: 1097-1102
33. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Sources and perceived credibility of vaccine-safety information for parents. Pediatrics. 2011 ; 127: S107 - S112
34. Allen JD, Othus MK, Shelton RC, et al. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev. 2010 ; 19: 2187-2198
35. Shui IM, Weintraub ES, Gust DA. Parents concerned about vaccine safety: differences in race/ethnicity and attitudes. Am J Prev Med. 2006 ; 31: 244-251
36. Lichtenstein B. Stigma as a barrier to treatment of sexually transmitted infection in the American deep south: issues of race, gender and poverty. Soc Sci Med. 2003 ; 57: 2435-2445
37. Kane MA, Sherris J, Coursaget P, Aguado T, Cutts F. Chapter 15: HPV vaccine use in the developing world. Vaccine. 2006 ; 24: S3/132 - S3/139
38. Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries - key challenges and issues. N Engl J Med. 2007 ; 356: 1908-1910